Simulating Signalling Pathways With BioWayS  by Chiarugi, Davide et al.
Simulating Signalling Pathways With
BioWayS
Davide Chiarugi 1 Moreno Falaschi2 Diana Hermith3
Dipartimento di Ingegneria dell’Informazione e Scienze Matematiche
Universita` degli Studi di Siena. Italy.
Michell Guzman4
Escuela de Ingenier´ıa de Sistemas y Computacio´n.
Universidad del Valle Cali. Colombia.
Carlos Olarte5
Departamento de Electro´nica y Ciencias de la Computacio´n.
Universidad Javeriana Cali. Colombia.
Abstract
We report on a technique for modelling biological systems based on the ntcc calculus, a model of concurrency
where systems are speciﬁed by means of constraints (i.e., formulae in logic). We show that the ability of
ntcc to express partial information, concurrency, non-determinism and timed behaviour makes it well-
suited model and simulate biochemical reactions networks. Based on this technique, we introduce BioWayS
(BIOchemical pathWAY Simulator), a software tool for the quantitative modelling and analysis of biological
systems. We show the applicability of BioWayS in the context of two well-studied biological systems: the
glycogen breakdown pathway and the life cycle of the human immunodeﬁciency virus.
Keywords: Signaling pathways, Concurrent Constraint Programming, biological systems.
1 Introduction
Computational biology aims at using methods and techniques from computer sci-
ence to integrate the existing knowledge concerning individual genes, proteins and
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molecules and to investigate the behaviour and relationships among the various el-
ements composing a biological system. A technique widely used in computational
biology consists in the construction of executable models (EMs) [15] describing the
studied systems as computer programs. EMs are typically speciﬁed through formal
languages based either on process algebras (e.g. [10,12,11,25,3]) or other formalisms
such as logic [9] or rewriting logic [14], constraint programming [21,13] or Petri nets
[6]. These models can be used for analyzing either static, qualitative properties
of biological systems [7] or their quantitative, dynamical behaviour. In the latter
case, for taking into account dynamical aspects, the evolution of the model is driven
by algorithms that, given the state of the system at one initial time t0, allows to
compute the state of the system at a subsequent time t. Depending on the chosen
algorithm the model results to be stochastic or deterministic.
Recently there has been a signiﬁcant interest in (executable) discrete stochastic
(DS) models of biological systems, mainly because experimental data are provid-
ing evidences that stochasticity arising at the molecular level plays an important
role in determining the overall behaviour of living organisms [30]. In DS models
the evolution of the system is driven by a stochastic algorithm which computes
the probability of state transitions according to given probability density functions
(PDFs). Biochemical reactions are often modelled through DS approaches, typi-
cally by describing the reaction system in hand as a discrete-state continuous-time
Markov process (DCMP) (see e.g. [4]). Gillespie’s Stochastic Simulation Algorithm
(SSA) [17], based on previous proposals (e.g. [4]), is the most widespread algo-
rithm used for implementing DS simulations of biological systems. Gillespie’s SSA
requires that some hypotheses are satisﬁed, namely solutions are well stirred and in
thermal equilibrium and, more importantly, it holds only for elementary chemical
reactions i.e., those reactions occurring in one reactive event. Even though it has
been shown that the SSA can work besides the prescribed scope of applicability
as proved by the success of various stochastic models against experimental data, it
is diﬃcult to describe biochemical systems in terms of elementary reactions: often
there is an incomplete knowledge of the full set of elementary reactions and meso-
scopic or macroscopic transformations are the only observable ones. Most commonly
this problem is circumvented abstracting away the unobservable elementary steps,
lumping them in a single reaction event modelled as a single “Markov jump” with
the waiting time τ sampled from a negative exponential distribution depending on
an overall rate constant. However, abstractions usually introduce approximations
in the behaviour of the models. The impact of these approximations is not easy
to evaluate or estimate, as noticed by Gillespie in [31] for enzymatically catalyzed
reactions. One crucial point in this abstraction approach concerns the modelling
of the waiting time, i.e. the time needed for a reaction to occur: even though the
elementary reactions underlying a given biochemical process can be modelled as a
DCMP (and, thus, with waiting times distributed according to a negative exponen-
tial PDF) on a mesoscopic or macroscopic scale the process may exhibit diﬀerent
dynamics such as non-Markovian behaviours, as pointed out also in [26] and [10]
and shown by various experimental evidence, e.g. [24]. These arguments suggest the
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need of proposing modelling approaches embedding a more general notion of tran-
sition time allowing to describe the observed time courses of biological phenomena
without assuming a memoryless process. Various approaches have been proposed
for addressing this issue. In [6] an extension for Petri Nets is proposed, while in [26]
the Beta Workbench toolkit is enhanced allowing the sampling of transition times
from non-exponential PDFs. BioPEPAd [10] allows to add deterministic delays to
the duration of a reaction. The work mentioned above propose diﬀerent approaches
in modelling reaction’s waiting times t. In [26] and [6], similarly to the Gillespie’s
SSA, t represents the time needed for the event reaction to be enabled, i.e. the time
needed for the reactants to collide eﬀectively and react. In these cases, the eﬀects
of the reactions (i.e. the formation of the products) are considered instantaneous.
Conversely, in [10] the enabling and the completion of the reactions are rendered as
two separated events and products formation is not instantaneous. As it will be de-
tailed in Sections 2 and 3 we consider t as the interval between two reactive events,
i.e. the time separating two subsequent events of product formation. In this way we
abstract the diﬀerence between the enabling and the eﬀects of a reaction without
subsuming whether product formation is instantaneous or not. This choice allow us
to model more faithfully experimental evidences. Indeed in (bio)chemistry and biol-
ogy the kinetics of reactions are measured observing product formation during time,
i.e. ”counting” the amount of molecules produced in given time intervals. Usually
these experiments do not provide information about which part of the time needed
for a reaction to occur is spent for the enabling or completion phase. Thus, focusing
on a more abstract notion of waiting time, we aim at preventing the insertion of
artifacts in modelling reaction dynamics.
In this paper we propose an approach based on the ntcc calculus [28], a tem-
poral extension of Concurrent Constraint Programming (CCP) [32], designed for
specifying and verifying timed and reactive systems. In particular we report on
BioWayS (BIOchemical pathWAY Simulator), a PHP based application designed
for specifying and executing ntcc models of biological systems. Other authors (see
e.g. [8]) used (extensions of) CCP for modelling biological systems. Anyway, up
to our knowledge, only a few of them (see e.g., [2,20]) focus on timed extensions of
CCP such as the ntcc calculus. In [2] the methods for describing living systems
through ntcc are presented at the theoretical level. In [20] the ntcc approach is
applied for specifying biological phenomena. This work integrates these propos-
als in three directions: (1) providing a systematic discussion of the features of the
ntcc-based modelling approach for biology; (2) presenting a ntcc-based working
software; (3) modelling and analyzing two complex biological scenarios, namely, the
glucagon-induced glycogen breakdown and the life cycle of the human immunodeﬁ-
ciency virus (HIV).
As we shall show, ntcc oﬀers several advantages in the modelling of biochemical
reaction systems: (1) the timed nature of the calculus allow us to faithfully model
temporal information about interactions, information about the temporal occurrence
of an event (e.g., when a binding occurs), and information about the relative ve-
locities of reactions (e.g., the duration of an interaction) thus allowing to take into
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account non-markovian dynamics. (2) Constraints in ntcc provide a compact rep-
resentation of the state of the system, (e.g., the concentration of the components
along the time). (3) ntcc models can be seen as executable: ntcc processes can
be straightforwardly executed and the evolution of the system can be observed.
Finally, (4) the ntcc calculus is equipped with an underlying temporal logic that
allows to formally specify and verify properties of the model. Notice that, with
respect to the process algebra-based approaches, CCP allows an explicit notion of
states based on constraints as well as an explicit notion of time. Summing up, the
contribution of this paper is twofold: on the one hand we present both a systematic
discussion of the main features that makes ntcc suitable for modelling biological
systems and; the software tool designed for simulating biological phenomena en-
joying the features of the ntcc based approach. On the other hand we apply our
technique for modelling and analyzing two complex biological systems.
The rest of the paper is structured as follows: In Section 2 we describe the ntcc
calculus. In Section 3 we present our software tool (BioWayS) on two examples
(the glycogen breakdown pathway and the HIV life cycle). Section 4 concludes the
paper.
2 Timed Concurrent Constraint Programming
Process calculi such as CCS and the π-calculus among several others have arisen
as mathematical formalisms to model and reason about concurrent systems. They
treat concurrent processes much like the λ-calculus treats computable functions.
They then provide a language in which the structure of terms represents the struc-
ture of processes together with an operational semantics to represent computational
steps.
In this paper we shall use as modelling language Concurrent Constraint Pro-
gramming (CCP) [32], a model for concurrency that combines the traditional oper-
ational view of process calculi with a declarative view based on logic. This allows
CCP to beneﬁt from the large set of reasoning techniques of both process calculi
and logic [32,28].
Agents in CCP interact with each other by telling and asking information rep-
resented as constraints to a global store. Constraints (e.g., x > 42) can be thought
of as formulae in a ﬁrst-order language and they represent (partial) information
about the variables of the system. Partial must be understood here as the fact that
constraints do not necessarily determine completely the values of the variables.
The basic constructs in CCP are the tell agent tell(c) that adds the constraint
c (via logical conjunction) to the store, thus making it available to the other pro-
cesses; and the ask process when c do P that queries if the current store d can
entail (deduce) the guard c, written d |= c; if so, it behaves like P . Otherwise it
remains blocked until more information is added. Hence, ask processes deﬁne a
synchronisation mechanism based on entailment of constraints. CCP features also
constructs for declaring local variables as in (localx)P and for executing processes
in parallel as in P ‖ Q.
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The ntcc calculus [28] extends CCP with the notion of discrete time-units to
model timed and reactive systems. Roughly speaking, a CCP-like process is exe-
cuted in a time-unit. When the resting point is reached, i.e., no further evolution
is possible, the store is output and a new time-unit is created to later execute the
continuation of the process. In order to specify this kind of behaviour, ntcc extends
CCP with operators such as nextP that delays the execution of P one time-unit;
the replication !P that executes P in all the time-units; and unless c nextP that
executes P in the next time-unit if c cannot be deduced from the store. Further-
more, ntcc introduces non-deterministic choices of the form
∑
i∈I when ci do Pi
where one Pi is chosen for execution if the guard ci can be entailed from the store.
When this happens, the other alternatives are precluded from execution. Asyn-
chronous behaviour is introduced by adding to the syntax a ﬁnite delay operator:
the process P represents a ﬁnite but unbounded delay for the activation of P .
The notion of constraint and the language of processes in ntcc are expressive
enough to specify the biological behaviour we are interested in modelling:
• Quantitative information can be naturally expressed by means of constraints. For
instance x > y states that the concentration of x is greater than that of y.
• Constraints provide also an elegant mechanism to represent partial information.
For instance, x > 42 gives some information regarding the concentration of x but
it does not give a speciﬁc value for it. This can be helpful when some compo-
nents of the system are not well known or we do not have enough quantitative
information about them.
• Synchronisation of ask processes via constraint entailment allow us to trigger
actions when some information can be derived from the system. For instance,
it is natural to express in the language that a given reaction occurs only when
certain component is present in the system.
• The ability of CCP to compose models (i.e., components) by parallel composition
leads to a robust modelling strategy: we can study separately components of a
system and then, observe the behaviour of the whole system.
• Timed operators as nextP allow us to describe reaction (or interactions) that
can take several time-units to be completed.
• Furthermore, since ntcc is a model of concurrency, we can use several techniques
to reason about the models we build. For instance, operational and denotational
semantics, model checking techniques and logical interpretation of processes (see
e.g., [32,28] ).
2.1 BioWayS: a ntcc model of biochemical reactions
The tool we propose here models biological systems by means of a set of reaction
rules of the form
a1X1 + ...anXn  b1Y1...+ bmYm (1)
The constants a1, ..., an and b1, ..., bm are the stoichiometric coeﬃcients. There-
fore, a1X1, a2X2, ..., anXn are reactants that interact (and then consumed) yielding
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to the products b1Y1, b2Y2, ..., bmYm.
In order to represent the reaction above, we model in ntcc each type of molecule
as a variable (e.g., Xi) and Equation (1) as the process
eq-proc = when X1 ≥ a1 ∧ ... ∧Xn ≥ an do
next (t) (tell(Y1 = Y
′
1 + b1 ∧ ... ∧ Ym = Y ′m + bm)) ‖
next tell(X1 = X
′
1 − a1 ∧ ... ∧Xn = X ′n − an)
(2)
We use primed variables to represent the value of the variables in the previous time
unit as in X1 = X
′
1. The process above can be read as “when the reactants are
available, they are consumed and the right-hand components are produced t time
units later”. Hence, the kinetic parameter t allow us to represent the speed of
reactions.
Assume now a set of n stoichiometric equations. We need a process that chooses
one of the reaction to occur at a given time-unit. This can be done by composing
each process eq-proci in a non-deterministic choice of the form:
∑
i∈1..n
eq-proci
Furthermore, if the propensity of each reaction to occur is available, it is possible
to consider probabilistic extensions of CCP as the one studied in [19]. Then, instead
of performing a non-deterministic choice, we can consider a probabilistic process of
the form:
new(p, F ) in
∑
i∈1..n
when p = i do eq-proci
where the value of p is chosen according to the probability mass function F for
{1, . . . , n}. For instance, for a system of two reactions, the process
new(p, F : F (1) = 0.2, F (2) = 0.8) in
∑
i∈1..2
when p = i do eq-proci
will choose with a probability of 0.2 the ﬁrst reaction and with a probability of 0.8
the second reaction.
Summing up, in BioWayS it is possible to express two important features of
biochemical reactions: the propensity (i.e. the probability of occurring) and the
duration, i.e. the time steps needed for the products to appear in the system. This
is an abstraction to represent the speed of a chemical reaction (i.e. the reaction rate
constant).
The model as a runnable speciﬁcation
Processes in ntcc can be seen as runnable speciﬁcations of a system: the model
can be directly simulated by using the operational semantics (SOS) of the calculus.
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The SOS dictates how processes evolve along time units. For instance, a process
tell(c) evolves into skip (the inactive process) by adding c to the current store d:
RTELL 〈tell(c), d〉 −→ 〈skip, d ∧ c〉
Similarly, for the rest of the processes. The reader may refer [28] for a complete
description of SOS rules of ntcc.
Following the operational rules of the calculus, we built an interpreter of ntcc on
top of the Mozart programming language (http://www.mozart-oz.org/). Central
to this implementation is the Mozart abstraction of a computation space (CS). A
CS is a constraint store where multiple threads can access (concurrently) the shared
variables and impose constraints on them. In Mozart, diﬀerent constraint systems
are available. Here we used the Finite Domain Constraint System (FD). In FD
variables are assumed to range over ﬁnite domains and, in addition to equality, we
may have predicates that restrict the possible values of a variable to some ﬁnite
set as in x > y. We thus model ntcc processes as threads that post and query
constraint in the CS until a resting point is reached. When this happens, we output
the ﬁnal store that contains the information about the variables of the model. This
gives a simple way to “execute” the ntcc model and observe the behaviour of the
modelled system in each time-unit.
In order to make the tool available on Internet, we embedded the ntcc interpreter
into BioWayS, a PHP based application freely available at http://avispa.puj.
edu.co. Users can build models of biological systems in BioWayS through a wizard
that comprises the following steps:
(i) Variables: Deﬁne the reacting species and their initial concentration.
(ii) System’s reactions: Deﬁne the type of reaction that describes how molecules
interact.
(iii) Propensity of reactions: Deﬁne the probability of each reaction to occur.
(iv) Duration of reactions: Deﬁne the duration of each type of interaction.
(v) Number of time-units: Time-window for the simulation.
3 Modelling
In this section we outline the use of our toolkit through the speciﬁcation and sim-
ulation of two well-studied biological scenarios: (i) the signalling pathway leading
to the glycogen breakdown into glucose 1-phosphate, and (ii) the life cycle of the
HIV. During the discussion we also highlight the features of our approach in these
speciﬁc cases.
3.1 The glycogen breakdown pathway: A model of intracellular processes
In higher organisms such as mammals glycogen is stored in the liver as a reservoir
of glucose. When the concentration of glucose in the blood is low the α cells of the
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pancreas secrete glucagon, a polypeptidic hormone which triggers the process of
glycogen breakdown (glycogenolysis). This process is started by the interaction of
glucagon with its receptor expressed by liver cells [1]. Once the glucagon receptor
embedded in the cell membrane binds its ligand, it activates a signal transduc-
tion pathway inside the cell leading to a glycogenolysis. More precisely, the signal
transduction system for the glycogen degradation pathway is modular and is made
of three type of proteins: (i) a receptor, (ii) a transducer, and (iii) an eﬀector.
Glucagon recognises and binds to its receptor causing an allosteric change [16].
Responding to this structural modiﬁcation, the transducer (a G-protein –guanine
nucleotide-binding protein– located in the inner side of the cell membrane) inter-
acts with the hormone-receptor complex stimulating a reaction in which a GDP
(guanosine diphosphate) molecule bound to the G-protein is replaced by GTP
(guanosine-5′-triphosphate). This reaction activates the G-protein, which then
interacts with the eﬀector, the enzyme adenylyl cyclase. This protein catalyses
the conversion of ATP (adenosine-5′-triphosphate) to cAMP (cyclic adenosine
monophosphate), an intracellular second messenger. Thus, the binding of glucagon
at the cell-surface stimulates the synthesis of a second messenger inside the cell,
which in turn stimulates a metabolic response (see Figure 1). The ﬁrst interaction
triggers a cascade of biochemical reactions in a signal transduction pathway through
the activation of G-proteins [1].
In order to model the system described above we apply a compositional approach
by adding iteratively biochemical interactions. This is particularly straightforward
in our framework: new information can be added to the system by posting con-
straints and the subsystems can be easily composed by sharing variables. Compo-
sitionality allows to build complex biological models combining partial information
coming from diﬀerent sources. This result is certainly more diﬃcult to achieve,
for example, in models based on ordinary diﬀerential equations (ODE) because the
large number of parameters needed and, in general, ODE are not compositional.
Moreover, the idea of partial information represented as constraints makes CCP
appropriate for this aim.
Note that our technique allows the description of the biological scenario at diﬀer-
ent levels of abstraction. For instance, in [21] we considered the interactions between
the transmembrane receptor and G-proteins in three diﬀerent environments (extra-
cellular, transmembrane, and intracellular). Now, we expand this perspective by
zooming into the intracellular domain with the aim to analyse the system’s be-
haviour at this level. This should allow us to gain a better understanding of the
system dynamics in response to the presence or absence of signalling molecules.
We describe the glycogen breakdown pathway through a set of reaction rules
resembling [13,21] and we considered the actions of binding, dissociation, complex
formation, and transfer of molecule groups. The full speciﬁcation of the model is
reported in Appendix A. For each reaction we speciﬁed the initial concentration c
of reactants , the probability p to occur and the time t (see parameter t in Equation
(2)) between two subsequent events of product formation. These parameters were
estimated accordingly to literature data [5,22,23,27,34]. In particular t is estimated
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Fig. 1. A reaction pathway for the glycogen breakdown (taken from [5] and
https://files.nyu.edu/gcl1/public/).
from reaction rates: the highest the reaction rate, the shortest t. We used c to set
the experimental conditions. Indeed we simulated diﬀerent scenarios (called modes
in the Appendix) in which c can be low, medium or high. For the simulations
performed here, we assumed that all reactions have the same propensity to occur.
Thanks to the timed nature of our modelling language, we are able to emphasise
the interactions between diﬀerent species during time.
Our in silico experiments show that the behaviour of our model is consistent
with that of the real counterpart. In particular, in liver cells, in response to the
hormone glucagon, the transmembrane protein adenylyl cyclase is stimulated and
catalyses the conversion of ATP into cAMP , an intracellular second messenger
(see Tables A.1 and A.2). This step of the signal transduction pathway is called
ampliﬁcation of the signal, since in response to a small amount of glucagon, a large
quantity of cAMP is produced (see Figure 2). The ampliﬁcation process is mediated
by subsequent molecular interactions. Indeed, before glucagon unbinds from its
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Fig. 2. Temporal trace of cAMP involved in the glycogen breakdown cascade. It can be observed an
increased formation of cAMP in presence of lower values of concentrations and rate constants, particularly
in terms of the extracellular ligand (see details in Appendix A.)
(a) (b)
Fig. 3. 3a Temporal trace for enzyme protein kinase A (cAMP dependent protein kinase (cAPK)) and 3b
glucose 1-phosphate.
receptor, several G-proteins can be activated. The activated proteins migrate along
the inner side of the plasma membrane and may enhance, in turn, the catalytic
capabilities of many adenylyl cyclases. Moreover, during the life-time of the G-
protein-adenylyl cyclase complex, several ATP molecules are converted into cAMP ,
thus leading to further ampliﬁcation.
Throughout the signal cascade, cAMP is capable to activate the enzyme protein
kinase A (cAMP dependent protein kinase (cAPK)). Thus, high levels of cAPK
are observed in the system (see Figure 3a). This environment is a requirement for the
activation of others intracellular signalling molecules (see Equations EQ8-EQ12.1 in
Appendix A) and to promote the degradation of glycogen into molecules of glucose
1-phosphate (see Figure 3b). Therefore, the processing of information from the
external environment to the intracellular medium, starts at the level of the cell
membrane through the binding of the hormone glucagon to its respective receptor
in a “physical interaction” followed by a set of biochemical reactions (transduction
pathway) in which the initial stimulus is greatly ampliﬁed.
Our representation of the interactions is in agreement with [33]: the following
enzymes must be both present and available for activation: glycogen phosphorylase
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(a) (b)
Fig. 4. 4a Temporal trace for proteins glycogen synthase (active form) and 4b glycogen phosphorylase
(inactive form).
kinase and glycogen phosphorylase, as well as protein kinase A must be available
for activation by cAMP . The enzyme adenylyl cyclase must be present according
with [29]. In line with [33,29] in almost all species the activity of glycogen synthase
increases rapidly while glycogen phosphorylase remains low, and the ratio of the
active forms of glycogen phosphorylase and glycogen synthase might be of major
importance in the regulation of metabolism. Our simulations (see Figure 4) repro-
duce this behaviour: enzyme glycogen synthase (active) increases in an overshoot
and afterwards decreases and remains in a constant level especially when we con-
sider the conﬁguration “medlimMode2” (see the blue arrow in Figure 4a) to perform
the simulations (see Tables A.1 and A.2). In such conﬁgurations the mid values of
concentrations and rate constants of the molecules and reactions in the network
are taken. When we consider the conﬁguration “medlimMode3” (see Tables A.1
and A.2), the glycogen phosphorylase (inactive) decreases to lower levels of con-
centration (see the blue arrow in Figure 4b). Moreover, we can notice that the ratio
and behaviour of the inactive/active forms of glycogen phosphorylase and glycogen
synthase aﬀects not only the degradation of glycogen to glucose 1-phosphate (the
active form of the glycogen phosphorylase degrades glycogen –see Equations EQ11-
11.1 in Appendix A) but also the glycogen synthesis (the active form of glycogen
synthase catalyses the formation of glycogen polymers –see Equations EQ12-12.1
in Appendix A). The ability of our modeling strategy and tool to easily adjust pa-
rameters and compose subsystems was crucial here to identify the above mentioned
behaviours and also to gain insights on the regulation of glycogenolysis.
3.2 The HIV life cycle: A representation based on biochemical interactions
Since the discovery of the human immunodeﬁciency virus (HIV), the etiologic agent
of the acquired immune deﬁciency syndrome (AIDS), scientists have studied the
dynamics and details of the HIV life cycle in order to develop eﬃcient antiviral
therapies. In the context of computational biology the dynamics of cell-virus in-
teractions have traditionally been investigated through both ODEs and EMs. In
the latter case the proposed modelling approaches mainly focus on membrane in-
teractions (see e.g. in [11]). We shall use here BioWayS for building a model of the
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HIV infection cycle shifting the focus on quantitative issues. Our aim is to track
the time course of a set of molecules during the various steps of the infection cycle.
Our investigation is driven by the available observations describing the progression
throughout the infection cycle as conditioned by the presence of certain molecules
in each phase. In other words, each stage of the infection cycle is characterised by
a precise set of molecules which are necessary for bootstrapping the following step.
Our interest in modelling the timing of this process reﬂects one research strategy
in drug discovery, aiming at blocking the infection cycle by interfering with the
bootstrapping molecules. Our framework promises to be particularly suited for this
purpose since time rates can be taken into account and ntcc processes can be pro-
gressively composed in order to build a model integrating information coming from
diﬀerent sources.
The various steps of the HIV infection process can be described as follows (see
[18] for a detailed description and Figure 5):
• Binding and Fusion: HIV binds to a speciﬁc receptor CD4 (cluster of diﬀerentia-
tion 4) and one of two co-receptors on the surface of a CD4+ T-lymphocyte and
fuses with the host cell releasing its RNA genome.
• Reverse Transcription: reverse transcriptase converts the single-stranded HIV
RNA to double-stranded HIV DNA.
• Integration: the HIV DNA enters the host cell’s nucleus where it may remain
inactive producing few or no new copies of HIV.
• Assembly: new virus particles are assembled in the host cell.
• Budding: the newly assembled virus pushes out (“buds”) from the host cell.
We used BioWayS to describe the interactions amongst the molecules of both the
virus and the host cell involved in the infection cycle. For this, we speciﬁed for each
reaction its duration and the initial amount of reactants. The equations composing
the model and the chosen parameters are reported in Appendix B. An interest-
ing observation that can be abstracted from the simulation results, is the cyclical
behaviour of the system based on the availability of the following molecules: ccr5
(C-C chemokine receptor type 5), cd4, gp41 (glycoprotein-membrane anchored fu-
sion protein subunit) and gp120 (glycoprotein-receptor binding domain) (see Figure
5). These molecules set a sort of boundary condition for the reaction scheme: if
they are not available to feed the system, the cycle is stopped.
BioWayS then allowed us to correctly identify a set of molecules whose presence
is a necessary condition for proceeding throughout each step of the infection cycle.
Consistently with available data, for instance, we found that in our model the
presence of the complex gp120/gp41 is necessary for both the Binding and Fusion
and the Budding phases. Without this complex, the virus is unable to infect the
host cell. Interestingly, drugs called Fusion Inhibitors, such as Maraviroc, block the
fusion phase interfering with the binding of the host-cell co-receptor ccr5 and the
complex gp120/gp41 : cd4 thus avoiding the HIV life cycle to continue.
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(a) (b)
Fig. 5. Steps of the replication of the virus (taken from http://www.niaid.nih.gov) (left) and the time
course of gp120/gp41 : cd4 : ccr5 necessary to initiate membrane fusion in the HIV life cycle (right).
4 Conclusions and future work
We have deﬁned a technique based on a temporal extension of Concurrent Con-
straint Programming (CCP) for modelling biological systems that allows us to rep-
resent straightforwardly transition times and partial information. In this paper we
have presented also a software tool (BioWayS) for modelling and analysing bio-
chemical interaction networks. Through two working examples we have illustrated
how our method can be used for gaining insights on the dynamics of biological
phenomena.
We are currently developing an extension of our toolkit allowing us to consider
also stochastic waiting times distributed according to non-exponential probability
distribution functions. This will lay the ground to describe a larger set of biological
scenarios.
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A Glycogen breakdown pathway
Below we list the reactions we considered for the simulation of the signaling
pathway of glycogen breakdown. In Table A.1 we describe the experimental
conditions, i.e., the rate constants for each reaction. Table A.2 describes the
component of the system along with the molar concentration we considered in each
simulation.
EQ1 Rglcgn[GαGDP ] + Lglcgn  Rglcgn[GαGTP ]Lglcgn
EQ2 Rglcgn[GαGTP ]Lglcgn  GαGTP + RglcgnLglcgn
EQ3 GαGTP +GAP  GAP−→GαGDP +GAP + Pi
EQ4 GαGDP + Rglcgn  Rglcgn[GαGDP ]
EQ5 RglcgnLglcgn  Rglcgn + Lglcgn
EQ6 GαGTP + AC  AC[GαGTP ]
EQ7 AC[GαGTP ] + ATP  [AC[GαGTP ]]ATP −→ cAMP + 2Pi + AC[GαGTP ]
EQ8 4cAMP + 2cAPKinact  2cAPKact
EQ9 cAPKact +GPKinact  [cAPKactGPKinact]
EQ9.1 [cAPKactGPKinact] + ATP−→(GPK − P )act + ADP + cAPKact
EQ10 (GPK − P )act +GPinact  [(GPK − P )actGPinact]
EQ10.1 [(GPK − P )actGPinact] + ATP−→(GP − P )act + ADP + (GPK − P )act
EQ11 (GP − P )act + Glycogen  (GP − P )actGlycogen
EQ11.1 (GP − P )actGlycogen + Pi −→ Glucose1 − P + (GP − P )act
EQ12 (GPK − P )act + cAPKact +GSact  [cAPKactGSact(GPK − P )act]
EQ12.1 [cAPKactGSact(GPK − P )act] + ATP−→(GS − P )inact + ADP + cAPKact + (GPK − P )act
Duration of a reaction
Equations Mode 1 Mode 2 Mode 3
EQ1: Receptor and G-protein activa-
tion
kf = 1, kb = 1 kf = 1, kb = 1 kf = 1, kb = 1
EQ2: G-protein and ligand dissocia-
tion
kf = 1, kb = 1 kf = 1, kb = 1 kf = 1, kb = 1
EQ3: GAP-driven GTPase process kf = 1, kb = 1, khydr =
1
kf = 1, kb = 1,
khydr = 1
kf = 1, kb = 1,
khydr = 1
EQ4: G-protein-receptor inactive com-
plex
kf = 1, kb = 1 kf = 1, kb = 1 kf = 1, kb = 1
EQ5: Receptor and ligand dissociation kf = 1, kb = 1 kf = 1, kb = 1 kf = 1, kb = 1
EQ6: G-protein (active) and adenylate
cyclase association
kf = 1, kb = 1 kf = 1, kb = 1 kf = 1, kb = 1
EQ7: cyclic AMP formation kf = 1, kb = 1,
kform = 1
kf = 1, kb = 1,
kform = 1
kf = 1, kb = 1,
kform = 1
EQ8: cAPK activation kf = 1, kb = 1 kf = 1, kb = 1 kf = 1, kb = 1
EQ9;EQ9.1: GPK phosphorylation kf = 1, kb = 1, k3 = 2 kf = 1, kb = 1, k3 =
20
kf = 1, kb = 1, k3 =
200
EQ10;EQ10.1: GP phosphorylation kf = 1, kb = 1, k5 = 2 kf = 1, kb = 1, k5 =
20
kf = 1, kb = 1, k5 =
200
EQ11;EQ11.1: Degradation of glyco-
gen to glucose 1-phosphate
kf = 1, kb = 1, kdegr =
1
kf = 1, kb = 1,
kdegr = 1
kf = 1, kb = 1,
kdegr = 1
EQ12;EQ12.1: GS phosphorylation kf = 1, kb = 1, k7 = 2 kf = 1, kb = 1, k7 =
20
kf = 1, kb = 1, k7 =
200
Table A.1
Reaction scheme in the signaling pathway of glycogen breakdown. The total time of the simulation was
1.000.000 time-units. The corresponding rate constant of a reaction is represented as its duration in
discrete time units. Adapted from [5,22,23,27,34].
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Variables Deﬁnition Concentration (nM)
Rglcgn[GαGDP ] GPCR-transm. glucagon receptor-Gα subunit 200;350;500
Lglcgn Ligand (glucagon) 1;500;1000
Rglcgn[GαGTP ]Lglcgn GPCR-G Protein-Ligand Complex 200;350;500
GαGTP G-protein GTP-bound alpha subunit (active) 200;1400;3000
RglcgnLglcgn Ligand-receptor complex 1;250;500
GAP GTP-hydrolysis enzyme 10;145;300
[GαGTP ]GAP GTP-hydrolysis complex 200;250;300
GαGDP G-protein GTP-bound alpha subunit (inactive) 200;1400;3000
Rglcgn GPCR- transmem. glucagon recep. 1;250;500
AC Adenylate cyclase enzyme 1;250;500
AC[GαGTP ] AC enzyme and G-protein complex 200;350;500
ATP Adenosine triphosphate 4000;4000;4000
[AC[GαGTP ]]ATP AC enzyme, G-protein and ATP complex 200;350;500
cAMP Cyclic AMP 1 × 105; 4.5 × 105; 1 × 106
Pi Inorganic phosphorus 4000;4000;4000
cAPKinact cAMP dependent protein kinase (inactive) 1000;1000;1000
cAPKact cAMP dependent protein kinase (active) 1000;1000;1000
GPKinact Glycogen phosphorylase kinase (inactive) 3000;3000;3000
[cAPKactGPKinact] cAPKactGPKinact complex 2000;2000;2000
(GPK − P )act Phosphorylate glycogen phosphorylase kinase 3000;3000;3000
ADP Adenosine diphosphate 4000;4000;4000
GPinact Glycogen phosphorylase (inactive) 7 × 104; 7 × 104; 7 × 104
[(GPK −
P )actGPinact]
glycogen phosphorylase kinase-glycogen phos-
phorylase complex
3000;3000;3000
(GP − P )act Glycogen phosphorylase (active) 7 × 104; 7 × 104; 7 × 104
Glycogen Glycogen 5 × 107;5 × 107;5 × 107
(GP−P )actGlycogen Glycogen phosphorylase-glycogen complex 7 × 104; 7 × 104; 7 × 104
Glucose1 − P Glucose 1-phosphate 5 × 107;5 × 107;5 × 107
GSact Glycogen synthase (active) 3000;3000;3000
[cAPKactGSact(GPK−
P )act]
Protein kinase glycogen synthase complex 1000;1000;1000
(GS − P )inact Glycogen synthase (inactive) 3000;3000;3000
Table A.2
Reacting species, their initial amount, and a model of biochemical reaction rules for the signaling pathway
of glycogen breakdown. For each mode of simulation, we use the lower, medium and upper limit of the
molar concentration of the variables: InfLim, MedLim, MaxLim, respectively. Adapted from
[5,22,23,27,34].
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B HIV infection cycle
Table B.1 describes the components of the system and the reactions considered for
the simulation of the HIV cycle.
Variables Deﬁnitions Biochemical Reaction Rules
gp120, gp41 Glycoprotein 120 - On the surface of the
HIV, glycoprotein 41 - Subunit of the
envelope protein complex
EQ1: gp120 + gp41 → [gp120]gp41
cd4 Cluster of diﬀerentiation 4 - Cell surface
glycoprotein
EQ2: [gp120]gp41 + cd4 → [[gp120]gp41]cd4
ccr5 C-C Chemokine receptor type 5 - Pro-
tein receptor for Chemokines
EQ3: [[gp120]gp41]cd4 + ccr5 →
[[[gp120]gp41]cd4]ccr5
ectgp41 Glycoprotein 41 ectodomain - Released
by a sequential binding of gp120 to cd4
and coreceptor
EQ4: [[[gp120]gp41]cd4]ccr5 → ectgp41
cpd Capsid - A shell containing the virus in-
formation
EQ5: ectgp41 → 2cpd
rT, int, prt Reverse transcriptase, integrase, pro-
tease - Enzymes released into the cell by
the virus
EQ6: cpd → rT + int + prt
sRNA Single-stranded Ribonucleic acid - ge-
netic information of the virus
EQ7: cpd → 2sRNA
dDNA Double-stranded Deoxyribonucleic acid
EQ8: 2sRNA + rT → dDNA
EQ9: dDNA + int → [dDNA]int
gnm Genome - genetic information of the cell EQ10: [dDNA]int + gnm → [[dDNA]int]gnm
vDNA Viral Deoxyribonucleic acid - viral infor-
mation produced by the genome
EQ11: [[dDNA]int]gnm → vDNA
mRNAHIV Viral messenger ribonucleic acid - viral
information used in order to produce the
viral proteins
EQ12: vDNA → mRNAHIV
pHIV
HIV viral protein-protein to be divided EQ13: prt + pHIV → [prt]pHIV
into small pieces by a protease EQ14: [prt]pHIV → 4prtv
prtv Viral proteins used to form new virus
EQ15: prtv → rTv
EQ16: prtv → prtvr
EQ17: prtv → intv
EQ18: prtv → 2sARNv
cpdv Viral capside - ontains the information
needed in order to form a new virus
EQ19: rTv + prtvr + intv → cpdv
EQ20: 2sARNv → cpdv
nV irus New virus - contains the information of
a new virus
EQ21: 2cpdv → nV irus
Table B.1
Reacting species, their initial amount, and a model of intracellular processes for the HIV life cycle. Our
simulation considers the parameter t = 1 (see Equation 2) and all the reactions have the same probability
to occur. Initial concentrations were set up to 100 copies for ccr5, cd4, gp120, gp41, and 0 for complexes.
Adapted from [18].
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